emmanuel_petiot_deinove_web

images-1
shutterstock_174261434

News

Roche to acquire Poseida Therapeutics

Roche has entered into a definitive merger agreement to acquire Poseida Therapeutics, a public clinical-stage biopharmaceutical company pioneering donor-derived CAR-T cell therapies. Based in San...

Attruby, a near complete TTR stabilizer (≥90%), approved by FDA to reduce cardiovascular death...

The U.S. Food and Drug Administration (FDA) has approved BridgeBio Pharma's Attruby (acoramidis), an orally-administered near-complete (≥90%) stabilizer of Transthyretin (TTR) for the treatment...

Arexvy approval expanded to adults aged 50-59 at increased risk of severe RSV disease...

Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved a regulatory application to extend the indication of GSK's Arexvy (respiratory syncytial virus vaccine,...